We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Plans a Response on Bydureon This Week, Estimates Health Reform Costs
Eli Lilly Plans a Response on Bydureon This Week, Estimates Health Reform Costs
April 19, 2010
Eli Lilly and its partners plan to submit a response this week to the FDA’s complete response letter on once-weekly diabetes drug Bydureon.